BioPharm International
July 01, 2009
Issue PDF
22
7
An Effective Way to Ensure Consistent Protein Expression
July 01, 2009
Compliance Notes
22
7
A culture of quality that emphasizes business objectives, risk management, and the informed application of technology can improve compliance.
July 01, 2009
Cover
22
7
Method for integration of transgenes.
July 01, 2009
Features
22
7
The introduction of two rival bills has intensified the long-simmering debate on biosimilars regulation in the US.
July 01, 2009
Burrill on Biotech
22
7
Although the markets closed on a positive note in May, it will still take many more months before biotech starts on the road to full recovery.
July 01, 2009
From the Editor
22
7
The truth is, we should have been afraid of H1N1, because the threat of a flu pandemic is real.
July 01, 2009
Perspectives on Outsourcing
22
7
By following key strategies, companies can reduce the risk and increase the benefits of outsourcing analytical development and testing
July 01, 2009
Features
22
7
How to produce Plasmid DNA in a high-cell-density culture.
July 01, 2009
Final Word
22
7
Biopharmaceutical companies must follow an active approach to managing their supply chains.
July 01, 2009
Regulatory Beat
22
7
The FDA seeks new strategies for improving the safe use of opioids and other high-risk medicines, including erythropoiesis stimulating agents.